Flu Vaccine Market Size

Flu Vaccine Market 2020 By Vaccine type(Quadrivalent, Trivalent), By Type( Seasonal, Pandemic), By Technology (Egg-based, Cell-based), By Age Group (Pediatric, Adult), By Route of Administration (Injection, Nasal Spray) 2025

  • Report ID: BMRC 736 | Number of pages: 200 | Publish Date: Feb 2020
    Status: Published | Category: Healthcare | Delivery Timeline: 48 hrs


COVID-19
To know the impact of COVID-19 On Flu Vaccine Market 2020 By Vaccine type(Quadrivalent, Trivalent), By Type( Seasonal, Pandemic), By Technology (Egg-based, Cell-based), By Age Group (Pediatric, Adult), By Route of Administration (Injection, Nasal Spray) 2025 Market

Request Now

Market Size Graph


Flu Vaccine Market, in terms of revenue, was worth of USD 4.82 Billion in 2018 and is expected to reach USD 7.06 Billion in 2025, growing at a CAGR of 5.64 % from 2019 to 2025.

Increasing government initiatives for wellbeing of population, minimum side effects associated with influenza vaccines, improvement in existing vaccines and development of new vaccines are some of the major factors driving the market growth. Additionally, funding and investments by major companies in research and development activities supports the growth of global market. Increasing cases of flu diseases among geriatric as well as pediatric population is helping to increase the market demand in flu seasons. On the positive side, rising number of routine immunization programs in developed as well as emerging countries is also expected to provide more opportunities for flu vaccine market growth.

Scope of The Report:

Flu Vaccine Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Flu Vaccine Market place for the forecast 2019– 2025. The global Flu vaccine is expected to grow at a significant rate due to the number of driving factors.

The study provides a crucial view of global Flu vaccine market by segmenting the market based on vaccine type, technology, application and region. On the basis of product type, the market is segmented into trivalent and quadrivalent. On the basis of technology, the market is segmented into egg based and cell based. Based upon application, the market is segmented into pediatrics and adults. On the basis of country level, global Flu vaccine market sub-divided into U.S., Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Brazil, Mexico, GCC, Africa, etc.

Flu Vaccine Manufacturers

  • Seqirus
  • GlaxoSmithKline Plc
  • Sanofi Pasteur SA
  • MedImmune
  • CSL Limited
  • Merck Sharp & Dohme Corp.
  • Pfizer, Inc.
  • Gamma Vaccines Pty Ltd
  • Sinovac Biotech Ltd
  • OPKO Health, Inc.

 

 

Key Benefits for Market Reports –

Global market report covers in depth historical and forecast analysis.

Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

Global market report helps to identify opportunities in market place.

Global market report covers extensive analysis of emerging trends and competitive landscape.

Flu Vaccine Market Key Market Segments:

By Vaccine type: Quadrivalent, Trivalent

By Type: Seasonal, Pandemic

By Technology: Egg-based, Cell-based

By Age Group: Pediatric, Adult

By Route of Administration: Injection, Nasal Spray

Market by Regional Analysis

The vaccine type segment of Flu vaccine market is dominated by Quadrivalent by capturing the largest market share XX% in year 2018 due to effectiveness of curing disease and technological breakthrough. In the technology segment egg-based gained the largest share XX % of this market in the year 2018 and expected to continue the same within the forecast period as it can be used by many people with fewer side effects. The application segment is dominated by Pediatrics by capturing XX % share of this market in the year 2018, due to increasing prevalence of disease in this category.

North America held the market share of XX% in 2018 of global Flu vaccine market within the forecast period. Major factors expected to drive the growth are increasing investment in research & development and rising geriatric population in this region. Increasing expansion of global players in Asia-pacific region and rising government policies of improving health of population are supplementing the growth of flu vaccine market in Asia-pacific region. Europe is expected to capture the XX% share of global Flu vaccine market in 2025.

Regional & Country Analysis
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa


Interested in this report?

Flu Vaccine Market 2020 | Size, trends, growth rate by 2025 and Analysis 2019-2025

report cover

Table of Content

Chapter 1 Global Flu Vaccine Market: Summary and Quantitative Analysis
1.1 Report Description
1.2 Global Flu Vaccine Market Revenue Overview
1.3 Global Flu Vaccine Market Revenue (USD Billion) and Growth (%) Rate, 2015- 2025

Chapter 2 Global Flu Vaccine Market: Overview and Qualitative Analysis
2.1 Executive Summary
2.2 Market Drivers
2.2.1 Increasing need to improve the process in order to comply with new standards is anticipated to witness a high growth of Flu Vaccine Market
2.3 Market Restraints
2.4 Market Opportunities
2.5 Market Trends
2.6 Global Flu Vaccine Market: SWOT Analysis
2.7 Global Flu Vaccine Market: PEST Analysis
2.8 Global Flu Vaccine Market: Attractiveness Analysis
2.8.1 Global Flu Vaccine Market: Attractiveness Analysis by Type
2.8.2 Global Flu Vaccine Market: Attractiveness Analysis by Grade
2.8.3 Global Flu Vaccine Market: Attractiveness Analysis by Regional

Chapter 3 Competitive Analysis
3.1 Global Flu Vaccine Market
3.1.1 Global Flu Vaccine market Revenue (USD Billion), By Players 2018
3.1.2 Global Flu Vaccine Market Revenue Share (%), By Players 2018

Chapter 5 Global Flu Vaccine Market: By Types
5.1 Global Flu Vaccine Market Share (%), By Types, 2018
5.2 Global Flu Vaccine Market Revenue (USD Billion), By Types, 2015 – 2025
5.3 Global Flu Vaccine Market Revenue (USD Billion), Based,2015-2025
5.4 Global Flu Vaccine Market Revenue (USD Billion), Based,2015-2025
5.5 Global Flu Vaccine Market Revenue Share (%), By Types, 2015 – 2025
5.6 Global Flu Vaccine Market Revenue Market Share (%), By Types, 2015-2025

Chapter 6 Global Flu Vaccine Market: By Application
6.1 Global Flu Vaccine Market Share (%), By Application, 2018
6.2 Global Flu Vaccine Market Revenue (USD Billion), By Application, 2015 – 2025
6.3 Global Flu Vaccine Market Revenue (USD Billion), Enterprises, 2015-2025
6.4 Global Flu Vaccine Market Revenue (USD Billion),2015-2025
6.5 Global Flu Vaccine Market Revenue Share (%), By Application, 2015 – 2025
6.6 Global Flu Vaccine Market Revenue Market Share (%), By Application, 2015-2025

Chapter 7 North America Flu Vaccine Market Analysis
7.1 North America Market Snapshot
7.1.1 North America Flu Vaccine Market Revenue and Growth Rate (%), 2015-2025.
7.1.2 North America Flu Vaccine Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
7.1.3 North America Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
7.1.4 North America Flu Vaccine Revenue (USD Billion) Overview, by Type, 2015-2025
7.1.5 North America Flu Vaccine Revenue (USD Billion) Overview, by Types, 2015-2025
7.1.6 North America Flu Vaccine Revenue (USD Billion) Overview, by Application , 2015-2025

Chapter 8 Europe Flu Vaccine Market Analysis
8.1 Europe Market Snapshot
8.1.1 Europe Flu Vaccine Market Revenue and Growth Rate (%), 2015-2025.
8.1.2 Europe Flu Vaccine Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
8.1.3 Europe Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
8.1.4 Europe Flu Vaccine Revenue (USD Billion) Overview, by Type, 2015-2025
8.1.5 Europe Flu Vaccine Revenue (USD Billion) Overview, by Types, 2015-2025
8.1.6 Europe Flu Vaccine Revenue (USD Billion) Overview, by Application, 2015-2025

Chapter 9 Asia Pacific Flu Vaccine Market Analysis
9.1 Asia Pacific Market Snapshot
9.1.1 Asia Pacific Flu Vaccine Market Revenue and Growth Rate (%), 2015-2025.
9.1.2 Asia Pacific Flu Vaccine Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
9.1.3 Asia Pacific Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
9.1.4 Asia Pacific Flu Vaccine Revenue (USD Billion) Overview, by Type, 2015-2025
9.1.5 Asia Pacific Flu Vaccine Revenue (USD Billion) Overview, by Types, 2015-2025
9.1.6 Asia Pacific Flu Vaccine Revenue (USD Billion) Overview, by Application, 2015-2025

Chapter 10 Latin America Flu Vaccine Market Analysis
10.1 Latin America Market Snapshot
10.1.1 Latin America Flu Vaccine Market Revenue and Growth Rate (%), 2015-2025.
10.1.2 Latin America Flu Vaccine Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
10.1.3 Latin America Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
10.1.4 Latin America Flu Vaccine Revenue (USD Billion) Overview, by Type, 2015-2025
10.1.5 Latin America Flu Vaccine Revenue (USD Billion) Overview, by Types, 2015-2025
10.1.6 Latin America Flu Vaccine Revenue (USD Billion) Overview, by Application, 2015-2025

Chapter 11 Middle East & Africa Flu Vaccine Market Analysis
11.1 Middle East & Africa Market Snapshot
11.1.1 Middle East & Africa Flu Vaccine Market Revenue and Growth Rate (%), 2015-2025.
11.1.2 Middle East & Africa Flu Vaccine Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
11.1.3 Middle East & Africa Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
11.1.4 Middle East & Africa Flu Vaccine Revenue (USD Billion) Overview, by Type, 2015-2025
11.1.5 Middle East & Africa Flu Vaccine Revenue (USD Billion) Overview, by Types, 2015-2025
11.1.6 Middle East & Africa Flu Vaccine Revenue (USD Billion) Overview, by Application, 2015-2025

Chapter 12 Competitive Analysis
12.1 COMPANY 1.
12.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.1.2 COMPANY 1. Total Company Revenue 2015-2018
12.1.3 COMPANY 1. Total Company Revenue, By Segment of Business 2015-2018
12.1.4 COMPANY 1. Total Company Revenue, By Region 2015-2018
12.1.5 COMPANY 1. Global Flu Vaccine Product Category and Description
12.1.6 COMPANY 1. Recent Activity 2015-2019
12.1.7 Main Business/Business Overview
12.1.8 Business Strategy
12.1.9 SWOT Analysis
12.2 Company 2.
12.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.2.2 Company 2. Total Company Revenue 2015-2018 117
12.2.3 Company 2. Total Company Revenue, By Segment of Business 2015-2018
12.2.4 Company 2. Total Company Revenue, By Region 2015-2018
12.2.5 Company 2. Global Flu Vaccine Product Category and Description
12.2.6 Company 2. Recent Activity 2015-2019
12.2.7 Main Business/Business Overview
12.2.8 Business Strategy
12.2.9 SWOT Analysis
12.3 COMPANY 3
12.3.1 Business Overview
12.3.2 COMPANY 3 Market Product Category and Description & Specification
12.3.3 Main Business/Business Overview
12.3.4 Business Strategy
12.3.5 SWOT Analysis
12.4 COMPANY 4
12.4.1 Business Overview
12.4.2 COMPANY 4 Company Total Company Revenue 2015-2018
12.4.3 COMPANY 4 Company Total Company Revenue, By Segment of Business 2015-2018
12.4.4 COMPANY 4 Company Total Company Revenue, By Region of Business 2015-2018
12.4.5 COMPANY 4 Company Product Category, Specification and Description
12.4.6 COMPANY 4 Company Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.4.7 COMPANY 4 Company Main Business/Business Overview
12.4.8 Business Strategy
12.4.9 SWOT Analysis
12.5 Company 5
12.5.1 Business Overview
12.5.2 Company 5 Company Net Sales 2015-2018
12.5.3 Company 5 Company Net Sales, By Segment of Business 2011-2018
12.5.4 Company 5 Company Net Sales, By Region 2015-2018
12.5.5 Company 5 Flu Vaccine Market Product Category and Specification
12.5.6 COMPANY 5 Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.5.7 COMPANY 5 Main Business/Business Overview
12.5.8 Business Strategy
12.5.9 SWOT Analysis
12.6 Company 6
12.6.1 Business Overview
12.6.2 Company 6 Flu Vaccine Market Product Category and Specification
12.6.3 Company 6 Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.6.4 Company 6 Main Business/Business Overview
12.6.5 Business Strategy
12.6.6 SWOT Analysis
12.7 Company 7
12.7.1 Business Overview
12.7.2 Company 7 Total Company Revenue 2015-2018
12.7.3 Company 7 Total Company Revenue, By Segment of Business 2015-2018
12.7.4 Company 7 Flu Vaccine Market Product Category and Description
12.7.5 Company 7 Recent Mergers &Acquisitions (M&A) Activity 2015-2019
12.7.6 Company 7 Main Business/Business Overview
12.7.7 Business Strategy
12.7.8 SWOT Analysis

Chapter 13 Market Research Findings & Conclusion

Chapter 14 Research Methodology
14.1 Research Process
14.2 Primary Research
14.3 Secondary Research
14.4 Market Size Estimates
14.5 Forecast Model
14.7 Who is This Report For?
14.8 USP’s of Report
?
List of Figures

FIG. 1 Global Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015- 2025
FIG. 3 Global Flu Vaccine Market: Attractiveness Analysis by Type
FIG. 4 Global Flu Vaccine Market: Attractiveness Analysis by Types
FIG. 5 Global Flu Vaccine Market: Attractiveness Analysis by Application
FIG. 6 Global Flu Vaccine Market: Attractiveness Analysis by Regional
FIG. 7 Global Flu Vaccine Market
FIG. 8 Global Flu Vaccine Market Share (%), By Type, 2018
FIG. 9 Global Flu Vaccine Market Revenue (USD Billion),
FIG. 10 Global Flu Vaccine Market Revenue (USD Billion),
FIG. 11 Global Flu Vaccine Market Revenue Market Share (%), By Type, 2015-2025
FIG. 12 Global Flu Vaccine Market Share (%), By Types, 2018
FIG. 13 Global Flu Vaccine Market Revenue (USD Billion), 2015-2025
FIG. 14 Global Flu Vaccine Market Revenue (USD Billion), 2015-2025
FIG. 15 Global Flu Vaccine Market Revenue Market Share (%), By Types, 2015-2025
FIG. 16 Global Flu Vaccine Market Share (%), By Application, 2018
FIG. 17 Global Flu Vaccine Market Revenue (USD Billion), By Large Enterprises, 2015-2025
FIG. 18 Global Flu Vaccine Market Revenue (USD Billion), 2015-2025
FIG. 19 Global Flu Vaccine Market Revenue Market Share (%), By Application, 2015-2025
FIG. 20 North America Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 21 North America Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 22 Europe Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 23 Europe Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 24 Asia Pacific Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 25 Asia Pacific Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 26 Latin America Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 27 Latin America Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 28 Middle East & Africa Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 29 Middle East & Africa Flu Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 30 COMPANY 1. Total Company Revenue 2015-2018 (USD Million, R & D Expenses %)
FIG. 31 COMPANY 1. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 32 COMPANY 1. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %)
FIG. 33 Company 2. Total Company Revenue 2015-2018 (USD Million)
FIG. 34 Company 2. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 35 Company 2. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %)
FIG. 36 COMPANY 4 Company Total Company Revenue 2015-2018 (USD Million)
FIG. 37 COMPANY 4 Company Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 38 COMPANY 4 Company Total Company Revenue, by Region of Business 2015-2018 (USD Million, AGR %)
FIG. 39 Company 5 Company Net Sales 2015-2018 (USD Million, R & D Expenses %)
FIG. 40 Company 5 Company Net Sales, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 41 Company 5 Company Net Sales, by Region 2015-2018 (USD Million, AGR %)
FIG. 42 Company 7 Total Company Revenue 2015-2018 (USD Million, R & D Expenses %)
FIG. 43 Company 7 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 44 Primary Research
FIG. 45 Sources of Secondary Research
FIG. 46 Forecast Model

List of Tables

TABLE 1 Global Flu Vaccine Market Overview
TABLE 2 Market Driver Impact Analysis
TABLE 3 Market Restraints Impact Analysis
TABLE 4 Global Flu Vaccine market Revenue (USD Billion), By Players2018
TABLE 5 Global Flu Vaccine market Revenue Market share (%), By Players- 2018
TABLE 6 Global Flu Vaccine Market Revenue (USD Billion), By Product Type, 2015 - 2025
TABLE 7 Global Flu Vaccine Market Revenue Share (%), By Type, 2015 - 2025
TABLE 8 Global Flu Vaccine Market Revenue (USD Billion), By Types, 2015 - 2025
TABLE 9 Global Flu Vaccine Market Revenue Share (%), By Types, 2015 - 2025
TABLE 10 Global Flu Vaccine Market Revenue (USD Billion), By Application, 2015 - 2025
TABLE 11 Global Flu Vaccine Market Revenue Share (%), By Application, 2015 - 2025
TABLE 12 North America Flu Vaccine market Revenue (USD Billion), by Country, 2015 - 2025
TABLE 13 North America Flu Vaccine Revenue (USD Billion), by Type, 2015-2025
TABLE 14 North America Flu Vaccine Revenue (USD Billion), by Types, 2015-2025
TABLE 15 North America Flu Vaccine Revenue (USD Billion), by Application , 2015-2025
TABLE 16 Europe Flu Vaccine market Revenue (USD Billion), by Country, 2015 - 2025
TABLE 17 Europe Flu Vaccine Revenue (USD Billion), by Type, 2015-2025
TABLE 18 Europe Flu Vaccine Revenue (USD Billion), by Types, 2015-2025
TABLE 19 Europe Flu Vaccine Revenue (USD Billion), by Application, 2015-2025
TABLE 20 Asia Pacific Flu Vaccine market Revenue (USD Billion), by Country, 2015 - 2025
TABLE 21 Asia Pacific Flu Vaccine Revenue (USD Billion), by Type, 2015-2025
TABLE 22 Asia Pacific Flu Vaccine Revenue (USD Billion), by Types, 2015-2025
TABLE 23 Asia Pacific Flu Vaccine Revenue (USD Billion), by Application, 2015-2025
TABLE 24 Latin America Flu Vaccine market Revenue (USD Billion), by Country, 2015 - 2025
TABLE 25 Latin America Flu Vaccine Revenue (USD Billion), by Type, 2015-2025
TABLE 26 Latin America Flu Vaccine Revenue (USD Billion), by Types, 2015-2025
TABLE 27 Latin America Flu Vaccine Revenue (USD Billion), by Application, 2015-2025
TABLE 28 Middle East & Africa Flu Vaccine market Revenue (USD Billion), by Country, 2015 - 2025
TABLE 29 Middle East & Africa Flu Vaccine Revenue (USD Billion), by Type, 2015-2025
TABLE 30 Middle East & Africa Flu Vaccine Revenue (USD Billion), by Types, 2015-2025
TABLE 31 Middle East & Africa Flu Vaccine Revenue (USD Billion), by Application, 2015-2025
TABLE 32 COMPANY 1. Basic Information, Manufacturing Base, Sales Area and Its Competitors
TABLE 33 Company 2. Basic Information, Manufacturing Base, Sales Area and Its Competitors
TABLE 34 COMPANY 4 Basic Information, Manufacturing Base and Competitors
TABLE 35 COMPANY 4 Company Basic Information, Manufacturing Base and Competitors
TABLE 36 Company 5 Basic Information, Manufacturing Base and Competitors
TABLE 37 Company 6 Basic Information, Manufacturing Base and Competitors
TABLE 38 Company 7 Basic Information, Manufacturing Base and Competitors

Flu Vaccine Market 2020 By Vaccine type(Quadrivalent, Trivalent), By Type( Seasonal, Pandemic), By Technology (Egg-based, Cell-based), By Age Group (Pediatric, Adult), By Route of Administration (Injection, Nasal Spray) 2025

  • Full Name * :
  • Bussiness Email * :
  • Job Title :
  • Company :
  • Contact No * :
  • Country * :
  • Any Query * :
  • Captcha * :
Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Choose License Type ( Price )

Single user license, allowing one specific user access to the product.
Multi-users license, allowing up to five users access to the product.
Corporte license . Allows all employees within your organization to access product.


American Express Citi Bank Credit/Debit Card Maestro Payment Master Card PayPal Visa Wire Transfer

+44-1173181773
alan@brandessenceresearch.biz


Looking for Regional Reports?